Browse All

Current Filters

CLEAR FILTER x

TITLE

The Phase 3 PROOF-HD Trial Demonstrates Meaningful Benefits of Pridopidine on Function, Cognition, and Motor Signs in Huntington Disease (HD)

Author:Geva, Michal   Reilmann, Ralf   Feigin, Andrew   Rosser, Anne   Kostyk, Sandra   Chen, Kelly   Hand, Randal   Boot, Diderik   Cohen, Yael   Goldberg, Paul   Hayden, Michael   

Session Name:PL5: Clinical Trials Plenary Session  

Topic:Movement Disorders  

Program Number:PL5.002  

Author Institution:Prilenia Therapeutics, Herzlyia, Israel  George-Huntington-Institute, Muenster, Germany  NYU Langone Health, New York, NY  Ohio State University College of Medicine, Dublin, OH  Prilenia Therapeutics, Kibbutz Yakum, Israel  Prilenia Therapeutics and University of British Columbia, Herzliya, Israel  

The Effect of Antidopaminergic Medications on Changes in Clinical Measures of Huntington’s Disease Function, Cognition, Motor Signs, and Progression

Author:Hand, Randal   Geva, Michal   Goldberg, Paul   Chen, Kelly   Long, Jeffrey   Hayden, Michael   

Session Name:P10: Movement Disorders: Hyperkinetic Movement Disorders: Dystonia, Chorea, Tics, Myoclonus, and RLS  

Topic:Movement Disorders  

Program Number:P10.030  

Author Institution:Prilenia Therapeutics, Kibbutz Yakum, Israel  Prilenia Therapeutics and University of British Columbia, Kibbutz Yakum, Israel